Home ›

Publications

Filters: Author is Solé, X  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
B
Solé X, Bonifaci N, López-Bigas N, Berenguer A, Hernández P, Reina O, et al. Biological convergence of cancer signatures. PloS one. 2009;4(2):e4544.
Aguilar H, Solé X, Bonifaci N, Serra-Musach J, Islam A, López-Bigas N, et al. Biological reprogramming in acquired resistance to endocrine therapy of breast cancer. Oncogene. 2010;29(45):6071-83. Abstract
C
Valls J, Grau M, Solé X, Hernández P, Montaner D, Dopazo J, et al. CLEAR-test: combining inference for differential expression and variability in microarray data analysis. Journal of biomedical informatics. 2008;41(1):33-45.
Sanz-Pamplona R, Berenguer A, Cordero D, Riccadonna S, Solé X, Crous-Bou M, et al. Clinical Value of Prognosis Gene Expression Signatures in Colorectal Cancer: A Systematic Review. PloS one. 2012;7(11):e48877. Abstract
G
Fernández-Ramires R, Solé X, De Cecco L, Llort G, Cazorla A, Bonifaci N, et al. Gene expression profiling integrated into network modelling reveals heterogeneity in the mechanisms of BRCA1 tumorigenesis. British journal of cancer. 2009;101(8):1469-80.
Solé X, Hernández P, de Heredia ML, Armengol L, Rodríguez-Santiago B, Gómez L, et al. Genetic and genomic analysis modeling of germline c-MYC overexpression and cancer susceptibility. BMC genomics. 2008;9:12.
Maxwell CA, Moreno V, Solé X, Gómez L, Hernández P, Urruticoechea A, et al. Genetic interactions: the missing links for a better understanding of cancer susceptibility, progression and treatment. Molecular cancer. 2008;7:4.
Vendrell E, Ribas M, Valls J, Solé X, Grau M, Moreno V, et al. Genomic and transcriptomic prognostic factors in R0 Dukes B and C colorectal cancer patients. International journal of oncology. 2007;30(5):1099-107.
I
Hernández P, Solé X, Valls J, Moreno V, Capellá G, Urruticoechea A, et al. Integrative analysis of a cancer somatic mutome. Molecular cancer. 2007;6:13.
M
Pujana MA, Ruiz A, Badenas C, Puig-Butille JA, Nadal M, Stark M, et al. Molecular characterization of a t(9;12)(p21;q13) balanced chromosome translocation in combination with integrative genomics analysis identifies C9orf14 as a candidate tumor-suppressor. Genes, chromosomes & cancer. 2007;46(2):155-62. Abstract
N
Pujana MA, Han JD, Starita LM, Stevens KN, Tewari M, Ahn JS, et al. Network modeling links breast cancer susceptibility and centrosome dysfunction. Nature genetics. 2007;39(11):1338-49.
P
Urruticoechea A, Aguilar H, Sole X, Capella G, Martin LA, Dowsett M, et al. Pre-clinical validation of early molecular markers of sensitivity to aromatase inhibitors in a mouse model of post-menopausal hormone-sensitive breast cancer. Breast Cancer Res. Treat.. 2008;109:463-70.
R
Della Gatta G, Palomero T, Perez-Garcia A, Ambesi-Impiombato A, Bansal M, Carpenter ZW, et al. Reverse engineering of TLX oncogenic transcriptional networks identifies RUNX1 as tumor suppressor in T-ALL. Nature medicine. 2012;18(3):436-40. Abstract
S
González JR, Armengol L, Solé X, Guinó E, Mercader JM, Estivill X, et al. SNPassoc: an R package to perform whole genome association studies. Bioinformatics (Oxford, England). 2007;23(5):644-5.
T
De Keersmaecker K, Real PJ, Gatta GD, Palomero T, Sulis ML, Tosello V, et al. The TLX1 oncogene drives aneuploidy in T cell transformation. Nature medicine. 2010;16(11):1321-7. Abstract
Sanz-Pamplona R, Berenguer A, Sole X, Cordero D, Crous-Bou M, Serra-Musach J, et al. Tools for protein-protein interaction network analysis in cancer research. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. 2012;14(1):3-14. Abstract
U
Balart J, Pueyo G, de Llobet LI, Baro M, Sole X, Marin S, et al. The use of caspase inhibitors in pulsed-field gel electrophoresis may improve the estimation of radiation-induced DNA repair and apoptosis. Radiation oncology (London, England). 2011;6(1):6. Abstract